Androxal(R) Second Pivotal Study Achieves Superiority in Top Line Analysis for Both Co-Primary Endpoints Versus Marketed Topical Gel in the Treatment of Secondary Hypogonadism
http://finance.yahoo.com/news/androxal-r-second-pivotal-study-002000815.html
http://finance.yahoo.com/news/androxal-r-second-pivotal-study-002000815.html